InvestorsHub Logo
Followers 53
Posts 5408
Boards Moderated 0
Alias Born 09/16/2013

Re: None

Friday, 02/21/2020 11:04:55 AM

Friday, February 21, 2020 11:04:55 AM

Post# of 2833
Actinium Shares Up After Study Mid-Point Analysis
7:55 AM ET 2/21/20 | Dow Jones


By Michael Dabaie

Actinium Pharmaceuticals Inc. said findings were positive from the mid-point analysis of the pivotal Sierra trial of Iomab-B.

Shares were up 15.5% premarket, to 29 cents.

The company said the findings from the trial showed substantially lower rates of febrile neutropenia and sepsis in patients receiving Iomab-B compared to patients receiving salvage chemotherapy in the control arm.

Write to Michael Dabaie at michael.dabaie@wsj.com

> Dow Jones Newswires

February 21, 2020 07:55 ET (12:55 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Stay strong, NWBO topline announcement is near!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News